The requirements for medicine are getting higher and higher, and the cure rate of cancer is increasingly attracting attention. CRISPR/cas9 genome editing technology has gradually attracted more and more attention, and has gradually become popular in research. At present, CRISPR system has been applied in many tumor immunotherapy methods and cancer research. CRISPR system is one of the key issues today, but there is still a lack of unified cognition about applying CRISPR in immunological therapy about cancer. Therefore, the theme of this study is about CRISPR in anti-tumor immunotherapy. More and more researchers are using CRISPR/cas system to improve and innovate the immunotherapy of various types of tumors, which improves the treatment efficiency and effect. At the same time, they provide innovative ideas and feasible ways for more treatment methods. CRISPR system also has some disadvantages, such as off-target effect. With the development of science and technology and more and more innovation and practice, crispr has been applied to cancer treatment to provide a good experience for patients.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: